Gender | Secondary malignant neoplasm of female breast | Chemotherapy Regimen Planned Completed | Therapeutic procedure Discontinue Planned
Item
women with metastatic breast cancer who are completing planned course of chemotherapy with planned treatment break
boolean
C0079399 (UMLS CUI [1])
C0346993 (UMLS CUI [2])
C0392920 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
C0205197 (UMLS CUI [3,3])
C0087111 (UMLS CUI [4,1])
C1444662 (UMLS CUI [4,2])
C1301732 (UMLS CUI [4,3])
Hormone Therapy Stable
Item
on stable hormone therapy for at least 2 months are also eligible for the study
boolean
C0279025 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
Life Expectancy
Item
estimated survival of at least 3 months
boolean
C0023671 (UMLS CUI [1])
Platelet Inhibitors
Item
no platelet inhibitor therapy within 1 month of study entry
boolean
C0032188 (UMLS CUI [1])
Platelet Count measurement
Item
platelets >= 100,000
boolean
C0032181 (UMLS CUI [1])
Blood coagulation screening test Normal Range International Normalized Ratio
Item
coagulation screening tests within normal range (inr between 0.81 and 1.20)
boolean
C3516413 (UMLS CUI [1,1])
C0086715 (UMLS CUI [1,2])
C0525032 (UMLS CUI [1,3])
Normal renal function | Liver function
Item
normal kidney and liver function as defined by:
boolean
C0232805 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
ast/alt <= 2 x institutional normal
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Creatinine measurement, serum
Item
creatinine <= 2 x institutional normal
boolean
C0201976 (UMLS CUI [1])
Informed Consent
Item
able to provide signed, informed consent.
boolean
C0021430 (UMLS CUI [1])
Operative Surgical Procedure Planned
Item
patients going on to surgery
boolean
C0543467 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Blood Coagulation Disorder Serious | Patients Inappropriate Non-Steroidal Anti-Inflammatory Agents
Item
patients with a serious bleeding disorder that make them inappropriate candidates for nsaid therapy
boolean
C0005779 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0030705 (UMLS CUI [2,1])
C1548788 (UMLS CUI [2,2])
C0003211 (UMLS CUI [2,3])
Hemorrhage Significant Peptic Ulcer Related
Item
patients with history of significant bleeding related to peptic ulcer disease
boolean
C0019080 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0030920 (UMLS CUI [1,3])
C0439849 (UMLS CUI [1,4])
Non-Steroidal Anti-Inflammatory Agents Dose Stable | Platelet Inhibitors
Item
patients on standing doses of nsaids or platelet function inhibitors
boolean
C0003211 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0032188 (UMLS CUI [2])
Anticoagulants Dose Stable
Item
patients on standing doses of anti-coagulants
boolean
C0003280 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])